Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 3d agoAfter-hours26.10.22 05:514Ownership#●●●
Niki BioSolutions, Inc.
Insider Laura A. Philips of Niki BioSolutions, Inc. has filed a Form 4 report regarding changes in beneficial ownership of securities as of July 22, 2026. This filing serves as an official disclosure of insider equity transactions.…more
$1.85+10.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 3d agoAfter-hours26.10.22 05:514Ownership
Niki BioSolutions, Inc.
Insider Kira Sheinerman has filed a Form 4 to report a change in beneficial ownership of securities for Niki BioSolutions, Inc., effective as of July 22, 2026. This filing serves as a standard disclosure of changes in insider shareholdings.…more
$1.85+10.12%vs prev closeView filingShare - 3d agoAfter-hours26.10.22 05:504Ownership
Niki BioSolutions, Inc.
Insider Kira Sheinerman of Niki BioSolutions, Inc. reported a change in beneficial ownership of securities effective July 22, 2026. This filing serves as the official record of the insider's equity transaction via Form 4.…more
$1.85+10.12%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoPre-market26.10.23 21:00#●●●#●●●
Niki BioSolutions Signs APOE Genotyping Supply Agreement with Charter Research…more
Niki BioSolutions has entered into an agreement to provide APOE genotyping services to Charter Research for their clinical trials. While this partnership expands the company's clinical research support, the lack of disclosed financial terms keeps the impact on the stock neutral.…more
$1.85+10.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.16Pre-market26.10.16 21:00
●●●●●●●● ●●●●● ●●●●●●
Niki BioSolutions' subsidiary, DiamiR, was featured in the International Rett Syndrome Foundation's research series for its blood-based biomarker panel. The program highlights the technology's potential in monitoring disease progression and treatment response in clinical settings.…more
$1.85+10.12%vs prev close - 10.14Pre-market26.10.14 21:03
●●●●●●●● ●●●●● ●●●●●●
Niki BioSolutions' subsidiary DiamiR will conduct APOE genotyping on plasma samples for the Global Alzheimer’s Platform Foundation's Bio-Hermes-002 study. This analysis will provide critical genetic data for clinical trial design and risk assessment without requiring additional blood draws.…more
$1.85+10.12%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report